{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T22:33:32Z","timestamp":1787956412186,"version":"build-2784847793"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"},{"start":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T00:00:00Z","timestamp":1771977600000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0"}],"funder":[{"DOI":"10.13039\/100008460","name":"National Center for Complementary and Integrative Health","doi-asserted-by":"publisher","award":["UG3\/UH3-AT0009757"],"award-info":[{"award-number":["UG3\/UH3-AT0009757"]}],"id":[{"id":"10.13039\/100008460","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J GEN INTERN MED"],"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Veterans filing musculoskeletal disorder (MSD) service claims may also be seeking medical treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>To determine the effect of Motivational Interviewing to Activate Pain Support (MAPS) on pain and substance use in veterans who recently filed MSD claims.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Participants<\/jats:title>\n                    <jats:p>A total of 1101 post 9\/11 veterans who had filed MSD compensation claims, were not receiving multimodal pain care from VA and had at least moderately severe pain.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Interventions<\/jats:title>\n                    <jats:p>Up to five phone sessions of MAPS compared to treatment-as-usual (TAU).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Main Measures<\/jats:title>\n                    <jats:p>Pain severity subscale of the Brief Pain Inventory (BPI) and number of substances above the low-risk threshold of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Key Results<\/jats:title>\n                    <jats:p>\n                      Most (87%) veterans offered MAPS participated, and counselors delivered MAPS with good integrity. At week 36, MAPS participants had significantly greater reductions in pain severity than TAU (\u22120.78 vs.\u2009\u22120.53; mean difference\u2009=\u2009\u2009\u22120.25, 95% CI\u2009\u22120.44 to\u2009\u22120.06,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u2009.011), although rates of clinically meaningful improvement were similar between groups (45.4% MAPS vs. 40.8% TAU; OR\u2009=\u20091.21, 95% CI 0.92\u20131.59,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u2009.183). The groups did not differ in\n                      <jats:italic>self-reported<\/jats:italic>\n                      number of pain treatment modalities used (TAU\u2009=\u20093.01 modalities vs. MAPS 3.33 modalities,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009=\u2009.135); however, MAPS participants had, on average, 54% more outpatient encounters for MSDs than those in TAU (MAPS 7.25 vs. TAU 4.58,\n                      <jats:italic>p<\/jats:italic>\n                      \u2009&lt;\u2009.001). Substance use did not differ between groups.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusions<\/jats:title>\n                    <jats:p>MAPS was associated with more outpatient encounters for MSD and statistically significant reductions in pain severity at week 36; reductions achieving the threshold for clinical significance did not differ by group. Benefits from MAPS, despite pandemic-era disruptions to treatment availability, may have occurred via counselors activating patients to seek MSD treatments, helping them navigate pain care systems, and offering patients support.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Design<\/jats:title>\n                    <jats:p>Two-arm, parallel group 36-week multisite randomized pragmatic clinical trial (Clinical Trials.gov: NCT 04062214).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Trial Registration<\/jats:title>\n                    <jats:p>ClinicalTrials.gov registration (NCT04062214) on August 19, 2019.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1007\/s11606-025-10127-2","type":"journal-article","created":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T20:24:05Z","timestamp":1772051045000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Motivational Interviewing Targeting Pain and Substance Use in Veterans Seeking Service-Connection Payments: A Multisite Randomized Clinical Trial"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5460-354X","authenticated-orcid":false,"given":"Marc I.","family":"Rosen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Gilstad-Hayden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina M.","family":"Lazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Sellinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Mattocks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul G.","family":"Barnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bradley R.","family":"Brummett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana M.","family":"Higgins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Holtzheimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas A.","family":"Livingston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tu","family":"Ngo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas E.","family":"Reznik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brad","family":"Schimelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia M.","family":"Semiatin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn","family":"Solzhenitsyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Martino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2026,2,25]]},"reference":[{"key":"10127_CR1","doi-asserted-by":"crossref","unstructured":"Gundlapalli AV, Redd AM, Suo Y, et al. Predicting and Planning for Musculoskeletal Service-Connected Disabilities in VA Using Disability for Active Duty OEF\/OIF Military Service Members. Mil Med. 2020;185(Supplement_1):413\u20139.","DOI":"10.1093\/milmed\/usz223"},{"key":"10127_CR2","unstructured":"Veterans Benefits Administration Annual Benefits Report Fiscal Year 2023."},{"key":"10127_CR3","doi-asserted-by":"crossref","unstructured":"Morasco BJ, Gritzner S, Lewis L, Oldham R, Turk DC, Dobscha SK. Systematic review of prevalence, correlates, and treatment outcomes for chronic non-cancer pain in patients with comorbid substance use disorder. Pain. 2011;152(3):488-97.","DOI":"10.1016\/j.pain.2010.10.009"},{"key":"10127_CR4","doi-asserted-by":"crossref","unstructured":"Morasco BJ, Corson K, Turk DC, Dobscha SK. Association between substance use disorder status and pain-related function following 12 months of treatment in primary care patients with musculoskeletal pain. J Pain. 2011;12(3):352-9.","DOI":"10.1016\/j.jpain.2010.07.010"},{"key":"10127_CR5","doi-asserted-by":"crossref","unstructured":"Trafton JA, Oliva EM, Horst DA, Minkel JD, Humphreys K. Treatment needs associated with pain in substance use disorder patients: implications for concurrent treatment. Drug Alcohol Depend. 2004;73(1):23-31.","DOI":"10.1016\/j.drugalcdep.2003.08.007"},{"key":"10127_CR6","doi-asserted-by":"crossref","unstructured":"Spinola S, Fenton BT, Meshberg-Cohen S, Black AC, Rosen MI. Comparison of attitudes towards the service connection claims process among veterans filing for PTSD and veterans filing for musculoskeletal disorders. Medicine (Baltimore). 2021;100(35):e27068.","DOI":"10.1097\/MD.0000000000027068"},{"key":"10127_CR7","doi-asserted-by":"crossref","unstructured":"Sayer NA, Thuras P. The influence of patients' compensation-seeking status on the perceptions of veterans affairs clinicians. Psychiatr Serv. 2002;53(2):210-2.","DOI":"10.1176\/appi.ps.53.2.210"},{"key":"10127_CR8","unstructured":"Miller WR, Rollnick S. Motivational Interviewing : Helping People Change and Grow. 4th ed. New York, NY: Guilford Press; 2023."},{"key":"10127_CR9","doi-asserted-by":"crossref","unstructured":"Borsari B, Li Y, Tighe J, et al. A pilot trial of collaborative care with motivational interviewing to reduce opioid risk and improve chronic pain management. Addiction (Abingdon, England). 2021;116(9):2387-97.","DOI":"10.1111\/add.15401"},{"key":"10127_CR10","doi-asserted-by":"crossref","unstructured":"Alperstein D, Sharpe L. The efficacy of motivational interviewing in adults with chronic pain: A meta-analysis and systematic review. J Pain. 2016;17(4):393-403.","DOI":"10.1016\/j.jpain.2015.10.021"},{"key":"10127_CR11","doi-asserted-by":"crossref","unstructured":"Frost H, Campbell P, Maxwell M, et al. Effectiveness of Motivational Interviewing on adult behaviour change in health and social care settings: A systematic review of reviews. PLoS One. 2018;13(10):e0204890.","DOI":"10.1371\/journal.pone.0204890"},{"key":"10127_CR12","doi-asserted-by":"crossref","unstructured":"Jiang S, Wu L, Gao X. Beyond face-to-face individual counseling: A systematic review on alternative modes of motivational interviewing in substance abuse treatment and prevention. Addict Behav. 2017;73:216-35.","DOI":"10.1016\/j.addbeh.2017.05.023"},{"key":"10127_CR13","doi-asserted-by":"crossref","unstructured":"Rosen MI, Becker WC, Black AC, Martino S, Edens EL, Kerns RD. Brief Counseling for Veterans with Musculoskeletal Disorder, Risky Substance Use, and Service Connection Claims. Pain Med. 2019;20(3):528-42.","DOI":"10.1093\/pm\/pny071"},{"key":"10127_CR14","doi-asserted-by":"crossref","unstructured":"Kerns RD, Brandt CA. NIH-DOD-VA Pain Management Collaboratory: Pragmatic Clinical Trials of Nonpharmacological Approaches for Management of Pain and Co-occurring Conditions in Veteran and Military Health Systems: Introduction. Pain Med. 2020;21(Suppl 2):S1-s4.","DOI":"10.1093\/pm\/pnaa358"},{"key":"10127_CR15","doi-asserted-by":"crossref","unstructured":"Martino S, Lazar C, Sellinger J, et al. Screening, Brief Intervention, and Referral to Treatment for Pain Management for Veterans Seeking Service-Connection Payments for Musculoskeletal Disorders: SBIRT-PM Study Protocol. Pain medicine (Malden, Mass). 2020;21(12 Suppl 2):S110-S7.","DOI":"10.1093\/pm\/pnaa334"},{"key":"10127_CR16","doi-asserted-by":"crossref","unstructured":"Stout RL, Wirtz PW, Carbonari JP, Del Boca FK. Ensuring balanced distribution of prognostic factors in treatment outcome research. J Stud Alcohol Drugs Suppl. 1994;12:70-5.","DOI":"10.15288\/jsas.1994.s12.70"},{"key":"10127_CR17","doi-asserted-by":"crossref","unstructured":"Dahlhamer J, Lucas J, Zelaya C, et al. Prevalence of Chronic Pain and High-Impact Chronic Pain Among Adults - United States, 2016. MMWR Morb Mortal Wkly Rep. 2018;67(36):1001-6.","DOI":"10.15585\/mmwr.mm6736a2"},{"key":"10127_CR18","unstructured":"Cleeland CS, Ryan KM. Pain assessment: global use of the Brief Pain Inventory. Annals of the Academy of Medicine, Singapore. 1994;23(2):129\u201338."},{"key":"10127_CR19","doi-asserted-by":"crossref","unstructured":"Dworkin RH, Turk DC, Wyrwich KW, et al. Interpreting the clinical importance of treatment outcomes in chronic pain clinical trials: IMMPACT recommendations. J Pain. 2008;9(2):105-21.","DOI":"10.1016\/j.jpain.2007.09.005"},{"key":"10127_CR20","doi-asserted-by":"crossref","unstructured":"Salaffi F, Stancati A, Silvestri CA, Ciapetti A, Grassi W. Minimal clinically important changes in chronic musculoskeletal pain intensity measured on a numerical rating scale. Eur J Pain. 2004;8(4):283-91.","DOI":"10.1016\/j.ejpain.2003.09.004"},{"key":"10127_CR21","unstructured":"World Health Organization. The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) Manual for use in primary care 2010. Available from: http:\/\/apps.who.int\/iris\/bitstream\/10665\/44320\/1\/9789241599382_eng.pdf."},{"key":"10127_CR22","doi-asserted-by":"crossref","unstructured":"Krebs EE, Lorenz KA, Bair MJ, et al. Development and initial validation of the PEG, a three-item scale assessing pain intensity and interference. J Gen Intern Med. 2009;24(6):733-8.","DOI":"10.1007\/s11606-009-0981-1"},{"key":"10127_CR23","unstructured":"Humeniuk R, Ali R, World Health Organization APIISG. Validation of the Alcohol, Smoking and Substance Involvement Screening Test (ASSIST) and pilot brief intervention [electronic resource] : a technical report of phase II findings of the WHO ASSIST Project \/ prepared by Rachel Humeniuk & Robert Ali, on behalf of the WHO ASSIST Phase II Study Group. Geneva: World Health Organization; 2006."},{"key":"10127_CR24","doi-asserted-by":"crossref","unstructured":"Ondersma SJ, Svikis DS, Schuster CR. Computer-based brief intervention a randomized trial with postpartum women. Am J Prev Med. 2007;32(3):231-8.","DOI":"10.1016\/j.amepre.2006.11.003"},{"key":"10127_CR25","doi-asserted-by":"crossref","unstructured":"Edmond SN, Kerns RD, Geda M, et al. Initial development of a self-report survey on use of Nonpharmacological and Self-Care Approaches for Pain management (NSCAP). Pain Med. 2024;25(Supplement_1):S14-s6.","DOI":"10.1093\/pm\/pnae082"},{"key":"10127_CR26","doi-asserted-by":"crossref","unstructured":"Coleman BC, Purcell N, Geda M, et al. Assessing the impact of the COVID-19 pandemic on pragmatic clinical trial participants. Contemp Clin Trials. 2021;111:106619.","DOI":"10.1016\/j.cct.2021.106619"},{"key":"10127_CR27","doi-asserted-by":"crossref","unstructured":"Sellinger JJ, Gilstad-Hayden K, Lazar C, et al. Impact of the COVID-19 pandemic on participants in pragmatic clinical trials for chronic pain: implications for trial outcomes and beyond. Pain Med. 2024;25(Supplement_1):S17-s27.","DOI":"10.1093\/pm\/pnae060"},{"key":"10127_CR28","doi-asserted-by":"crossref","unstructured":"Kroenke K, Spitzer RL, Williams JB. The PHQ-9: validity of a brief depression severity measure. J Gen Intern Med. 2001;16(9):606-13.","DOI":"10.1046\/j.1525-1497.2001.016009606.x"},{"key":"10127_CR29","unstructured":"2024 Survey of Veteran Enrollees' Health and Use of Health Care. 2024 January, 2024. at  https:\/\/www.statista.com\/statistics\/1369773\/veterans-enrolled-in-the-va-health-care-system-by-age-in-the-us\/. Accessed  23 July 2025."},{"key":"10127_CR30","doi-asserted-by":"crossref","unstructured":"Hibbard JH, Mahoney ER, Stockard J, Tusler M. Development and testing of a short form of the patient activation measure. Health Serv Res. 2005;40(6 Pt 1):1918-30.","DOI":"10.1111\/j.1475-6773.2005.00438.x"},{"key":"10127_CR31","doi-asserted-by":"crossref","unstructured":"Hibbard JH, Greene J. What the evidence shows about patient activation: better health outcomes and care experiences; fewer data on costs. Health Aff (Millwood). 2013;32(2):207-14.","DOI":"10.1377\/hlthaff.2012.1061"},{"key":"10127_CR32","doi-asserted-by":"crossref","unstructured":"Matthias MS, McGuire AB, Kukla M, Daggy J, Myers LJ, Bair MJ. A brief peer support intervention for veterans with chronic musculoskeletal pain: a pilot study of feasibility and effectiveness. Pain medicine (Malden, Mass). 2015;16(1):81-7.","DOI":"10.1111\/pme.12571"},{"key":"10127_CR33","doi-asserted-by":"crossref","unstructured":"Hammett PJ, Eliacin J, Makris UE, et al. An Analysis of the Role of Mental Health in a Randomized Trial of a Walking Intervention for Black Veterans With Chronic Pain. J Pain. 2023;24(1):55-67.","DOI":"10.1016\/j.jpain.2022.07.002"}],"container-title":["Journal of General Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-025-10127-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s11606-025-10127-2","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s11606-025-10127-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T20:24:11Z","timestamp":1772051051000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s11606-025-10127-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,2,25]]},"references-count":33,"alternative-id":["10127"],"URL":"https:\/\/doi.org\/10.1007\/s11606-025-10127-2","relation":{},"ISSN":["0884-8734","1525-1497"],"issn-type":[{"value":"0884-8734","type":"print"},{"value":"1525-1497","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,2,25]]},"assertion":[{"value":"6 August 2025","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 December 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"25 February 2026","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"Participants provided audio recorded informed consent to participate in this study. The study protocol (Clinical Trials.gov: NCT-04062214) and informed consent procedures were approved by the Yale University Institutional Review Board and VA Central Institutional Review Board (see protocol in Supplement\n                      \n                      ). A Data Safety and Monitoring Board convened by the National Center for Complementary and Integrated Health also approved the protocol and reviewed trial progress.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human Ethics and Consent to Participate Declarations"}},{"value":"None.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}}]}}